活血解毒法治疗冠心病搭桥并反复支架术后劳力性心绞痛1例
The Treatment of Coronary Heart Disease Bypass and Repeated Stent After Labor Angina 1 case
扫 描 看 全 文
1.中国中医科学院西苑医院急诊科 北京100091.
2.中国中医科学院西苑医院综合内科 北京100091.
3.北京中医药大学临床医学院北京西苑医院综合内科 100091
4.北京大学中医药临床医学院北京西苑医院 综合内科 100091
扫 描 看 全 文
张艳虹, 环璐瑶, 翁家俊, 等. 活血解毒法治疗冠心病搭桥并反复支架术后劳力性心绞痛1例[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29234616&Fpath=home&index=0
ZHANG Yanhong, HUAN Luyao, WENG Jiajun, et al. The Treatment of Coronary Heart Disease Bypass and Repeated Stent After Labor Angina 1 case[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29234616&Fpath=home&index=0
张艳虹, 环璐瑶, 翁家俊, 等. 活血解毒法治疗冠心病搭桥并反复支架术后劳力性心绞痛1例[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29234616&Fpath=home&index=0 DOI:
ZHANG Yanhong, HUAN Luyao, WENG Jiajun, et al. The Treatment of Coronary Heart Disease Bypass and Repeated Stent After Labor Angina 1 case[DB/OL].(2023-02-27)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails?columnId=29234616&Fpath=home&index=0 DOI:
病史摘要,2,发作性胸痛20余年,高血压病史20余年,加重2日。中医诊断 胸痹,气虚血瘀证。西医诊断 ①冠状动脉粥样硬化性心脏病;②冠状动脉支架植入术后状态;③冠状动脉搭桥术后;④陈旧性下壁后壁心肌梗死;⑤心功能不全Ⅱ-Ⅲ级;⑥高血压1级(极高危);⑦高脂血症。干预措施 中医方选愈梗通瘀汤加减以扶正益气、行气活血、化瘀通脉;常规西药治疗。疗效转归 六诊后随访,患者诉未再发过胸痛,快走后无胸前区不适,心慌发作频率明显减少,得以回归正常生活。
Summary of case history, Epistal chest pain for more than 20 years, the history of hypertension for more than 20 years, aggravated for 2 days.,TCM diagnosis, chest bi, qi deficiency and blood stasis syndrome.,Western medicine diagnosis, ① coronary atherosclerotic heart disease; ② after coronary stent implantation; ③ after coronary artery bypass grafting; ④ old inferior posterior wall myocardial infarction; ⑤ cardiac insufficiency-Ⅲ; ⑥ hypertension grade 1 (extremely high risk); ⑦ hyperlipidemia.,Therapeutic methods, Traditional Chinese medicine selects and reduce the soup to strengthen qi, promote qi and blood circulation, remove blood stasis and pulse; conventional western medicine treatment.,Clinical outcomes ,After six treatments, the patient described no recurrence of chest pain, no chest discomfort after fast walking, palpitation frequency significantly reduced, and was able to return to normal life.
高血压冠心病心绞痛
hypertensioncoronary heart diseaseangina pectoris
ENGELEN SE,ROBINSON AJB,ZURKE Y,et al.. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed[J]? Nat Rev Cardiol. 2022:1-21. Epub ahead of print.
CHOW C K,BRIEGER D,RYAN M,et al.Chow CK, Brieger D, Ryan M,et al. Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study[J]. Heart Asia. 2019,11(1):e011122.
DAGAN Misha,DINH D T,STEHLI J,et al.Sex Disparity in Secondary Prevention Pharmacotherapy and Clinical Outcomes Following Acute Coronary Syndrome.[J].Eur Heart J Qual Care Clin Outcomes,2021,8(4):420-428.
José Manuel Fragoso,Zu?iga-RamosJoaquín,Arellano-GonzálezMarva,et al.The t29c (rs1800470) polymorphism of the transforming growth factor-β1 ( tgf-β1 ) gene is associated with restenosis after coronary stenting in mexican patients[J].Exp Mol Pathol,2015,98(1):13-17.
ZhengRuyi,Yan Liu,HaoZirui,et al.Clinical characteristics and prognosis of young patients with coronary heart disease[J].Medical Science Monitor,2020,26:922957.
时之秀,杜训松,曹洁.老年冠心病患者PCI术后主要心脑血管不良事件发生情况及影响因素分析[J].临床心血管病杂志,2022,38(02):132-136.
尚坤,于清华,石光,等.老年冠心病的中医临床证治特点[J].中国老年学杂志,2018,38(08):2023-2024.
徐浩,史大卓,殷惠军,等."瘀毒致变"与急性心血管事件:假说的提出与临床意义[J].中国中西医结合杂志,2008(10):934-938.
盛松,徐凤芹,张艳虹.芎芍胶囊对动脉粥样硬化模型兔血脂和超敏C反应蛋白的影响[J].中西医结合心脑血管病杂志,2019,17(17):2595-2598.
梅俊,周庆兵,徐浩,等.芎芍胶囊药物组分协同降低RAW264.7源性泡沫细胞胆固醇含量及抗炎作用[J].中国动脉硬化杂志,2019,27(08):655-660.
梅俊,周庆兵,徐凤芹.芎芍胶囊含药血清对RAW264.7源性泡沫细胞胆固醇流出的影响[J].中国中西医结合杂志,2020,40(01):65-69.
Zhang YH, Zhang Y, Li J, et al. Protective effects of Xiongshao Capsule on anti-inflammatory function of high-density lipoprotein in an atherosclerosis rabbit model[J]. Chin J Integr Med. 2017,23(5):357-361.
陈畅,谢永艳,黄丽萍.荷叶碱药理作用的研究进展[J].南京中医药大学学报,2021,37(04):619-624.
Kompa AR, Lu J, Weller TJ, et al. Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction[J]. Int J Cardiol. 2018,258:192-198.
Khan Z, Gholkar G, Tolia S, et al. M. Effect of sacubitril/valsartan on cardiac filling pressures in patients with left ventricular systolic dysfunction[J]. Int J Cardiol. 2018,271:169-173.
LU Kangyun,Dass Kingsley Theras Primus,Lin ShinnZong,et al.N-butylidenephthalide ameliorates high-fat diet-induced obesity in mice and promotes browning through adrenergic response/ampk activation in mouse beige adipocytes.[J].Biochimica et biophysica acta. Molecular and cell biology of lipids,2021,1866(12):159033-159033.
于素玲,叶霄,贾国夫,等.青藏高原药用植物甘松研究进展[J].中国实验方剂学杂志,2021,27(19):243-250.
董庆海,吴福林,王涵,等.延胡索药学研究进展[J].中国野生植物资源,2019,38(01):48-53+79.
曹瑀莹,李劭恒,袁硕,等.人参抗心律失常作用机制的研究进展[J].中草药,2021,52(10):3157-3166.
孙小鑫,苗青,王瑞海,等.丹参-葛根药对成分、药理及临床应用的研究进展[J].世界科学技术-中医药现代化,2020,22(12):4308-4313.
沈迎,张瑞岩,沈卫峰.稳定性冠心病血运重建策略进展——2018中国稳定性冠心病诊断与治疗指南解读[J].心脑血管病防治,2019,19(02):107-111.
冠心病合理用药指南(第2版)[J].中国医学前沿杂志(电子版),2018,10(06):1-130.
0
浏览量
22
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构